Rankings
▼
Calendar
XOMAP (XOMA Corporation) Stock Financials & Earnings | Market Cap Arena
XOMAP
XOMA Corporation
Mkt Cap
$311M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$47M
Net Income (TTM)
$22M
EPS (TTM)
$2.10
Free Cash Flow (TTM)
$5M
Gross Margin
93.6%
Op. Margin
-15.0%
Net Margin
45.9%
FCF Margin
11.4%
P/S Ratio (TTM)
6.6x
P/E Ratio (TTM)
14.3x
YoY Rev Growth
+118.0%
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q4 22
$1M
$1M
-$6M
Q1 23
$437K
$383K
-$10M
Q2 23
$2M
$2M
-$6M
Q3 23
$830K
$805K
-$6M
Q4 23
$2M
$2M
-$20M
Q1 24
$1M
$1M
-$7M
Q2 24
$11M
$10M
-$10M
Q3 24
$7M
$7M
-$16M
Q4 24
$9M
$9M
-$16M
Q1 25
$16M
$15M
$6M
Q2 25
$13M
$12M
$5M
Q3 25
$9M
$8M
-$1M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q4 22
51.5x
—
Q1 23
92.5x
—
Q2 23
77.0x
—
Q3 23
70.4x
—
Q4 23
65.3x
—
Q1 24
53.4x
—
Q2 24
20.4x
—
Q3 24
14.4x
—
Q4 24
10.9x
—
Q1 25
7.2x
—
Q2 25
6.9x
—
Q3 25
6.6x
14.3x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q4 22
-$4M
-$4M
Q1 23
-$5M
-$5M
Q2 23
-$7M
-$7M
Q3 23
-$2M
-$2M
Q4 23
-$4M
-$4M
Q1 24
-$6M
-$6M
Q2 24
$3M
$3M
Q3 24
-$9M
-$9M
Q4 24
-$3M
-$3M
Q1 25
$2M
$2M
Q2 25
$6M
$6M
Q3 25
-$296K
-$296K
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q4 22
$0
Q1 23
$0
Q2 23
$0
Q3 23
$0
Q4 23
$17K
Q1 24
$17K
Q2 24
$0
Q3 24
$0
Q4 24
$3K
Q1 25
$0
Q2 25
$0
Q3 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q4 22
-95.9%
+37.9%
Q1 23
-85.9%
+105.1%
Q2 23
+68.7%
+32.4%
Q3 23
+84.0%
+37.2%
Q4 23
+23.4%
+182.8%
Q1 24
+241.0%
-19.9%
Q2 24
+568.6%
+177.9%
Q3 24
+767.1%
+245.1%
Q4 24
+375.4%
+14.7%
Q1 25
+967.9%
+17.5%
Q2 25
+18.4%
-59.7%
Q3 25
+29.9%
-53.2%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q4 22
$0
0.0%
Q1 23
$2M
359.3%
Q2 23
$0
0.0%
Q3 23
$3M
327.3%
Q4 23
$3M
144.5%
Q1 24
$0
0.0%
Q2 24
$3M
24.3%
Q3 24
$0
0.0%
Q4 24
$0
0.0%
Q1 25
$2M
12.5%
Q2 25
$0
0.0%
Q3 25
$0
0.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q4 22
$28K
$8M
$47K
Q1 23
$54K
$6M
$53K
Q2 23
$39K
$6M
$58K
Q3 23
$25K
$6M
$37K
Q4 23
$25K
$7M
$1M
Q1 24
$33K
$8M
—
Q2 24
$1M
$11M
$9M
Q3 24
$817K
$8M
—
Q4 24
$864K
$7M
$5K
Q1 25
$1M
$8M
$33K
Q2 25
$69K
$8M
—
Q3 25
$69K
$10M
—
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 22
$58M
$335K
$58M
Q1 23
$44M
$311K
$45M
Q2 23
$31M
$320K
$32M
Q3 23
$33M
$214K
$34M
Q4 23
$153M
$161K
$153M
Q1 24
$136M
$413K
$137M
Q2 24
$144M
$696K
$145M
Q3 24
$142M
$785K
$143M
Q4 24
$102M
$4M
$105M
Q1 25
$90M
$2M
$93M
Q2 25
$75M
$9M
$84M
Q3 25
$90M
$2M
$92M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q4 22
11M
+0.0%
Q1 23
11M
+0.1%
Q2 23
11M
+0.1%
Q3 23
11M
+0.1%
Q4 23
11M
+0.0%
Q1 24
12M
+0.9%
Q2 24
12M
+0.6%
Q3 24
12M
+0.6%
Q4 24
12M
+1.2%
Q1 25
12M
+0.0%
Q2 25
15M
+26.5%
Q3 25
18M
+21.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 13
$211K
168
FY 14
$103K
183
FY 15
$645K
86
FY 16
$309K
18
FY 17
$4M
12
FY 18
$482K
11
FY 19
$2M
10
FY 20
$3M
10
FY 21
$3M
12
FY 22
$502K
12
FY 23
$366K
13
FY 24
$2M
13
marketcaparena.com